SCHEMBL29295264

SCHEMBL29295264

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5c(-c6ccc7ccccc7c6)c6ccccc6c(-c6ccc7ccccc7c6)c5c4)c4ccccc34)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.47
ESR2 Q92731 8/20 0.47
HSD17B1 P14061 2/20 0.43
HSD17B2 P37059 2/20 0.43
CYP1A1 P04798 2/20 0.42
CYP1B1 Q16678 2/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2B6 P20813 1/20 0.41
CYP2C19 P33261 1/20 0.41
GSTP1 P09211 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259152 0.96 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL3460383 0.96 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL29375861 0.96 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL19720301 0.94 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL27367720 0.94 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL21238074 0.94 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL28538557 0.94 ESR1 (0.49) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL1013297 0.94 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL29330637 0.93 HSD17B1 (0.49) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL30730877 0.92 ESR1 (0.53) ESR1ESR2HSD17B1HSD17B2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237533-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO LTD (KR) 2024-07-11 US disclosed
US-20240228513-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO LTD (KR) 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228513-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES OR10J3, ORC3, C1R ESR1 1230/4885ESR2 1194/4885HSD17B1 3231/4885
US-20240237533-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES OR10J3, C1R, ORC3 ESR1 1295/4885ESR2 1316/4885HSD17B1 3172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.